ARTV as of Nov 6 · 14:54 ET
ARTVNasdaqBiological Products, (No Diagnostic Substances)

Artiva Biotherapeutics, Inc. · Brief

Next report

130 days

Mar 16 · after closeest.Q4 FY26

Expected move

No implied move.

Implied vs realized

2 reportsHistory
—≥ implied
Q2 FY26±35.1%▼−2.68%×0.08
Oct 27 '26±76.2%▼−30.68%×0.40
quarterimplied−80%0+80%realized×
Oct '26±76.2%▼−30.68%×0.40
Q2 FY26±35.1%▼−2.68%×0.08
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Mar 16 report · est.

Bull2

72managers reporting a position in the latest quarterly filings13F · Jun 30 '26
0 of 14largest reporting managers that cut their stake in the latest quarter13F · Jun 30 '26

Bear1

3tracked funds holding ARTVN-PORT · Aug 31 '26
AI captions · Nov 2 '26once per report · top 2 per case

Linked exposure

ARTV report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 27haltTrading halt: 07:25 ET, resumed 07:50 ET.Source
Oct 26impliedImplied move: ±76.2% into Oct 27 earnings (Oct 26 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.